The Truth Behind Phase 3 Hair Regrowth Claims: Hype Vs. Verified Dermatological Science
Why can no topical lotion fully restore bald skin to its original density? The answer rests inside the complex stem cell niche of the hair follicle. Within an active follicle, the dermal papilla directs matrix keratinocytes to generate the hair shaft. As androgenetic alopecia advances through level 3 thinning, DHT signaling prompts neighboring fibroblasts to synthesize excessive extracellular matrix proteins.
This gradual stiffening, known as follicular micro-inflammation and progressive fibrosis, eventually isolates the follicle from its microvascular supply. Once this structural scarring cements, the arrector pili muscle detaches and dermal papilla cell counts decline irreversibly.
Topical antiandrogens such as clascoterone 5% excel at intercepting the biochemical signal triggering that process. They stop further follicle miniaturization. They encourage dormant, half-miniaturized vellus-like hairs to revert back into pigmented, terminal strands. They cannot, however, generate de novo follicles on completely barren skin. Marketing campaigns often conflate "halting disease progression" with "wholesale regeneration." Patients must differentiate between the preservation of existing units and the creation of new ones.
